Mineralys Therapeutics, Inc.
(MLYS - NASDAQ)
26,99 USD
📋 Profilo Aziendale

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases.

|